版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
投資組合理論成功應(yīng)用的5個(gè)關(guān)鍵(英文)課件OverviewofPortfolioManagementTheFiveKeys1. CorporateBuy-in2. RiskManagement3. RevenueStream4. EfficiencyofInvestment5. ProfitSummaryContentsOverviewofPortfolioManagemeOverviewof
PortfolioManagementOverviewof
PortfolioManagemOverviewBASICCRITICALPOINTSTheR&Dportfolioisthefutureofthecompany.Tomanageitistodistributescarceresourcesacrossasetofprojectsaswellasacrossasetofprojectstrategies.Prioritiesmustbeestablishedanddifficultchoicesmustbemade.OverviewBASICCRITICALPOINTSMANAGEMENTREQUIRMENTSBecauseof‘surprises’,goodmanagementmeansflexibility.Ofcriticalimportanceisthatseniormanagementunderstandtheprinciples,theobjectives,andtheknowledgetomakecorrectchoices.OverviewMANAGEMENTREQUIRMENTSOverviewTHEGOALTheultimateaimistocreatevalueandtodoitovertime.Ifapharmaceuticaldoesitwell,thenitwillbesuccessful.Theoptimalportfolioisonewhich(1)maximisesexpectedvaluetodayandintothefuture,(2)addressesrisk(attrition),and(3)optimallydistributesresources.OverviewTHEGOALOverviewTheFiveEssentialKeysTheFiveEssentialKeysTheFiveEssentialKeysSELECTIONCRITERIAToqualifyasakey,eachfactorhadtomeetthefollowingcriteria:IthadtorelatetoallR&Dprojects,notjustasubset.Corporatemanagementcouldelect‘nottopursue’thefactor.Ifthecompanydidn’tdoit(byaccidentorbydesign),itwouldnotbesuccessful?TheFiveEssentialKeysSELECTIKey#1-CorporateBuy-inThismeansthatbothmanagementatalllevelsandprojectteammembersunderstandandarewillingtofollowtheprinciplesofPortfolioManagement.Thisiskeyfortwosimplereasons...Key#1-CorporateBuy-inThisKey#1-CorporateBuy-inManagement-
TheDecisionMakingProcessisthe1stStepinAchievingGoalsandObjectives.
Makingcorrectportfoliochoices,projectstrategies,resourceallocations,andtimingsaretheresponsibilityofCorporateManagement.Decisionmakersmustunderstandthenatureofdecisionmakingunderuncertaintyaswellasthequantitativemeasuresthatleadtosuccess.Key#1-CorporateBuy-inManagKey#1-CorporateBuy-inProjectTeams-
TheBestDecisionRequirestheBestInformationAvailableInformationisdatathatisputinaformthatallowsgoalsandobjectivestobepursued.Providingcorrectprojectdataistheresponsibilityofprojectteammembersandnooneelse.Theseindividualsrepresentexpertknowledgewhichisthebestinformationavailabletodecisionmakers.
Key#1-CorporateBuy-inProjeKey#1-CorporateBuy-inWithoutcorporatebuy-in,PortfolioManagementdoesnotexist.Asanalternative,onemayaskoneself,“DoIfeellucky?!”‘DirtyHarry’Key#1-CorporateBuy-inWithoKey#2-RiskManagementTheneedtomanageriskappearsobvious,but(1)itisnotalwaysdoneand(2)whenitisdone,itisnotalwaysdonecorrectly.Wewillconsider:1. Whathappenswhen‘risk’isnotassessedorused.2. Whysomedonotwanttoassessoruse‘risk’.3. Whatare‘right’and‘wrong’waysinwhichtouseit.Key#2-RiskManagementTheneKey#2-RiskManagement1. Whathappenswhen‘risk’isnotassessedorused.ValueBlockbuster
PotentialProbabilityofSuccessValueWorth
NothingKey#2-RiskManagement1. WhaKey#2-RiskManagementThetypicalexplanationasto‘why’riskisnotassessedis,“It’stooinaccuratetobeofanyuse.”2. Whysomedonotwanttoassessoruse‘risk’.DEADLYCLEANDEADLYCLEAN‘Risk’isactually‘uncertainty’and‘uncertainty’isactually‘confidence’.Theword‘inaccurate’isnotevenrelevantasitisactuallyadistributionofoutcomesforwhichanexperthassome,alot,ornoconfidence.Key#2-RiskManagementThetyKey#2-RiskManagementWRONGTwoimportantfactorsfordeterminingtheworthofadrugarethequalityofthescienceandthecommercialvalue.Bothareofequalweightasbotharecriticalforsuccess.ARPharma(averylargepharmaceutical)hasdecidedtousea0-10ratingforeachfactorthenaddthescores.Projectswillbeprioritizedbasedontheirindexoutofapossible20.3. Whatare‘right’and‘wrong’waysinwhichtouserisk?ProjectA-Scienceisavg.Scoreis5.
Commisavg.Scoreis5.
Index10ProjectB-Scienceisbad.Scoreis0.
Commisgood.Scoreis10.
Index10Key#2-RiskManagementWRONG3Key#2-RiskManagementWhatare‘right’and‘wrong’waysinwhichtouserisk?SAFETYEFFICACY50%50%50%50%$1b$250mProjectASAFETYEFFICACY1%99%1%9%$10b$1mProjectBRIGHTKey#2-RiskManagementWhataKey#3-RevenueStreamBlockbustersarenice,buttheyarefarandinbetween. Operatingcapitalisrequiredtosustainanybusinessintothefuture.Smallprojectsarethe‘bread&butter’ofapharmaceutical. Ifstrictadherenceispaidtoselectingthehighestvaluedopportunity,thenapharmaceuticalhastoaskitselfifitwillstillbearoundtoreapthosebenefitsinthefuture.Key#3-RevenueStreamBlockbuKey#4-EfficiencyofInvestmentEfficiencyissimplyarateofreturn.Thatis,it’sanindex.Ifyouhaveonedollartoinvestandyouaretryingtomaximizeyourreturn,thenputitintheprojectwiththegreatestROI.Ifyoudon’tdoit,yourstockholderswillandyou’llsoonfindyourselfoutofbusiness.ButROIisNOTvalue.WhatdoesitmeantothemanagerofanR&DPortfolio?Key#4-EfficiencyofInvestmKey#4-EfficiencyofInvestmentAnefficiencyindexsuchasROIorPRODUCTIVITY,canusedtopackasmuchvalueintoalimitedspaceasispossible.Whenselectingprojectstopursuefromalargenumber,orderthembyanefficiencymeasure,thenstopwhenyourunoutofmoney.You’llcreateyourhighestvaluedportfolio.(Onecaveatisthatyoucanimprovetotalvalueabitbyusingaspecialmathematicalmethodcalledintegerprogramming.)Key#4-EfficiencyofInvestmKey#4-EfficiencyofInvestmentOtherscarceresourcessuchaschemists,drugsubstance,manufacturingcapacity,andtimearesubjecttothesameprinciplesofdistribution.Putthemintothegreatestefficiencyprojectsfirst!(Iftheproblemistoocomplex,rememberthatintegerprogrammingwasdevelopedforjustsuchproblems.)Key#4-EfficiencyofInvestmKey#5-ProfitAnybusinessinanyuniversemustmakeaprofit,other-wisevalueisdestroyed.ValuedestructionfallsintothesameclassasAvacuum(whichnatureabhors),Blackholes(fromwhichnothingescapes)andThesecondlawofthermodynamics(aone-waystreetfromwhichonedoesnotreturn).Conclusion:Portfoliomanagementmustclearlycreatevalue.Allelseisnice,butnotnecessary.Key#5-ProfitAnybusinessinSummarySummaryCorporateBuy-inRiskManagementProductivityProjectCProjectIProjectBProjectFProjectHProjectGProjectEProjectDProjectJProjectALikelihoodofR&DSuccessNetPresentValueYearsRiskAdjustedNetSalesProjectIProjectBProjectFProjectGProjectEProjectJProjectARiskAdjustedCostsRiskAdjustedNPVValue
OptimisationBestUseofResources?OptimalGrowth?OptimalProjectPlan?OptimalRegionalPortfolio?OptimalTherapeuticportfolio?CorporateBuy-inRiskManagemenProbability(%)GoldStdValue(£)ProjectCProjectIProjectBProjectFProjectHProjectGProjectEProjectDProjectJProjectALikelihoodofR&DSuccessNetPresentValueRiskDistributionRiskManagementProbability(%)GoldStdValue(ProjectIYearsRiskAdjustedNetSalesControlCashFlowRevenueStreamandEfficiencyProjIProjBProjFProjGProjEProjJProjARiskAdjustedCostsRiskAdjustedNPVUseEfficiencyMeasuresProjectIYearsRiskAdjustedNeProjectCProjectIProjectBProjectFProjectHProjectGProjectEProjectDProjectJProjectALikelihoodofR&DSuccessNetPresentValueRisk-AdjustedNPVProfitSAFETYEFFICACYPRESENTATIONValuein£’s%ofOccurrenceCommercialEnvironmentProjectCProjectIProjectBProInSummaryThePortfoliorepresentsthefutureofacompany.Successisdeterminedbyvaluecreationtodayandinthefuture.Inthefaceofuncertainty,theuseof‘expected(risk-adjusted)values’tipstheoddsofwinninginfavorofdecisionmakers.The‘best’portfolioisthatwhichefficientlydistributesresourcesandmaximizesproductivity.InSummaryThePortfoliorepres投資組合理論成功應(yīng)用的5個(gè)關(guān)鍵(英文)課件OverviewofPortfolioManagementTheFiveKeys1. CorporateBuy-in2. RiskManagement3. RevenueStream4. EfficiencyofInvestment5. ProfitSummaryContentsOverviewofPortfolioManagemeOverviewof
PortfolioManagementOverviewof
PortfolioManagemOverviewBASICCRITICALPOINTSTheR&Dportfolioisthefutureofthecompany.Tomanageitistodistributescarceresourcesacrossasetofprojectsaswellasacrossasetofprojectstrategies.Prioritiesmustbeestablishedanddifficultchoicesmustbemade.OverviewBASICCRITICALPOINTSMANAGEMENTREQUIRMENTSBecauseof‘surprises’,goodmanagementmeansflexibility.Ofcriticalimportanceisthatseniormanagementunderstandtheprinciples,theobjectives,andtheknowledgetomakecorrectchoices.OverviewMANAGEMENTREQUIRMENTSOverviewTHEGOALTheultimateaimistocreatevalueandtodoitovertime.Ifapharmaceuticaldoesitwell,thenitwillbesuccessful.Theoptimalportfolioisonewhich(1)maximisesexpectedvaluetodayandintothefuture,(2)addressesrisk(attrition),and(3)optimallydistributesresources.OverviewTHEGOALOverviewTheFiveEssentialKeysTheFiveEssentialKeysTheFiveEssentialKeysSELECTIONCRITERIAToqualifyasakey,eachfactorhadtomeetthefollowingcriteria:IthadtorelatetoallR&Dprojects,notjustasubset.Corporatemanagementcouldelect‘nottopursue’thefactor.Ifthecompanydidn’tdoit(byaccidentorbydesign),itwouldnotbesuccessful?TheFiveEssentialKeysSELECTIKey#1-CorporateBuy-inThismeansthatbothmanagementatalllevelsandprojectteammembersunderstandandarewillingtofollowtheprinciplesofPortfolioManagement.Thisiskeyfortwosimplereasons...Key#1-CorporateBuy-inThisKey#1-CorporateBuy-inManagement-
TheDecisionMakingProcessisthe1stStepinAchievingGoalsandObjectives.
Makingcorrectportfoliochoices,projectstrategies,resourceallocations,andtimingsaretheresponsibilityofCorporateManagement.Decisionmakersmustunderstandthenatureofdecisionmakingunderuncertaintyaswellasthequantitativemeasuresthatleadtosuccess.Key#1-CorporateBuy-inManagKey#1-CorporateBuy-inProjectTeams-
TheBestDecisionRequirestheBestInformationAvailableInformationisdatathatisputinaformthatallowsgoalsandobjectivestobepursued.Providingcorrectprojectdataistheresponsibilityofprojectteammembersandnooneelse.Theseindividualsrepresentexpertknowledgewhichisthebestinformationavailabletodecisionmakers.
Key#1-CorporateBuy-inProjeKey#1-CorporateBuy-inWithoutcorporatebuy-in,PortfolioManagementdoesnotexist.Asanalternative,onemayaskoneself,“DoIfeellucky?!”‘DirtyHarry’Key#1-CorporateBuy-inWithoKey#2-RiskManagementTheneedtomanageriskappearsobvious,but(1)itisnotalwaysdoneand(2)whenitisdone,itisnotalwaysdonecorrectly.Wewillconsider:1. Whathappenswhen‘risk’isnotassessedorused.2. Whysomedonotwanttoassessoruse‘risk’.3. Whatare‘right’and‘wrong’waysinwhichtouseit.Key#2-RiskManagementTheneKey#2-RiskManagement1. Whathappenswhen‘risk’isnotassessedorused.ValueBlockbuster
PotentialProbabilityofSuccessValueWorth
NothingKey#2-RiskManagement1. WhaKey#2-RiskManagementThetypicalexplanationasto‘why’riskisnotassessedis,“It’stooinaccuratetobeofanyuse.”2. Whysomedonotwanttoassessoruse‘risk’.DEADLYCLEANDEADLYCLEAN‘Risk’isactually‘uncertainty’and‘uncertainty’isactually‘confidence’.Theword‘inaccurate’isnotevenrelevantasitisactuallyadistributionofoutcomesforwhichanexperthassome,alot,ornoconfidence.Key#2-RiskManagementThetyKey#2-RiskManagementWRONGTwoimportantfactorsfordeterminingtheworthofadrugarethequalityofthescienceandthecommercialvalue.Bothareofequalweightasbotharecriticalforsuccess.ARPharma(averylargepharmaceutical)hasdecidedtousea0-10ratingforeachfactorthenaddthescores.Projectswillbeprioritizedbasedontheirindexoutofapossible20.3. Whatare‘right’and‘wrong’waysinwhichtouserisk?ProjectA-Scienceisavg.Scoreis5.
Commisavg.Scoreis5.
Index10ProjectB-Scienceisbad.Scoreis0.
Commisgood.Scoreis10.
Index10Key#2-RiskManagementWRONG3Key#2-RiskManagementWhatare‘right’and‘wrong’waysinwhichtouserisk?SAFETYEFFICACY50%50%50%50%$1b$250mProjectASAFETYEFFICACY1%99%1%9%$10b$1mProjectBRIGHTKey#2-RiskManagementWhataKey#3-RevenueStreamBlockbustersarenice,buttheyarefarandinbetween. Operatingcapitalisrequiredtosustainanybusinessintothefuture.Smallprojectsarethe‘bread&butter’ofapharmaceutical. Ifstrictadherenceispaidtoselectingthehighestvaluedopportunity,thenapharmaceuticalhastoaskitselfifitwillstillbearoundtoreapthosebenefitsinthefuture.Key#3-RevenueStreamBlockbuKey#4-EfficiencyofInvestmentEfficiencyissimplyarateofreturn.Thatis,it’sanindex.Ifyouhaveonedollartoinvestandyouaretryingtomaximizeyourreturn,thenputitintheprojectwiththegreatestROI.Ifyoudon’tdoit,yourstockholderswillandyou’llsoonfindyourselfoutofbusiness.ButROIisNOTvalue.WhatdoesitmeantothemanagerofanR&DPortfolio?Key#4-EfficiencyofInvestmKey#4-EfficiencyofInvestmentAnefficiencyindexsuchasROIorPRODUCTIVITY,canusedtopackasmuchvalueintoalimitedspaceasispossible.Whenselectingprojectstopursuefromalargenumber,orderthembyanefficiencymeasure,thenstopwhenyourunoutofmoney.You’llcreateyourhighestvaluedportfolio.(Onecaveatisthatyoucanimprovetotalvalueabitbyusingaspecialmathematicalmethodcalledintegerprogramming.)Key#4-EfficiencyofInvestmKey#4-EfficiencyofInvestmentOtherscarceresourcessuchaschemists,drugsubstance,manufacturingcapacity,andtimearesubjecttothesameprinciplesofdistribution.Putthemintothegreatestefficiencyprojectsfirst!(Iftheproblemistoocomplex,rememberthatintegerprogrammingwasdevelopedforjustsuchproblems.)Key#4-EfficiencyofInvestmKey#5-ProfitAnybusinessinanyuniversemustmakeaprofit,other-wisevalueisdestroyed.ValuedestructionfallsintothesameclassasAvacuum(whichnatureabhors),Blackholes(fromwhichnothingescapes)andThesecondlawofthermodynamics(aone-waystreetfromwhichonedoesnotreturn).Conclusion:Portfoliomanagementmustclea
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年度生態(tài)環(huán)保渣土資源化利用承包合同4篇
- 2025年農(nóng)業(yè)大棚租賃與蔬菜種植一體化服務(wù)合同4篇
- 2025年度照明燈具代加工服務(wù)合同模板4篇
- 2025年度校園食堂炊事員職務(wù)聘用合同書3篇
- 2025年度智慧城市基礎(chǔ)設(shè)施大包工程合同4篇
- 2024版建設(shè)工程借款合同范本簡單
- 2025年度文化創(chuàng)意產(chǎn)業(yè)園租賃合同示范文本4篇
- 2025年度安保應(yīng)急響應(yīng)預(yù)案制定合同范本3篇
- 2024物業(yè)房屋裝修工程合同工程量清單
- 2024版酒類專賣店加盟的合同
- 物業(yè)民法典知識(shí)培訓(xùn)課件
- 2023年初中畢業(yè)生信息技術(shù)中考知識(shí)點(diǎn)詳解
- 2024-2025學(xué)年山東省德州市高中五校高二上學(xué)期期中考試地理試題(解析版)
- 《萬方數(shù)據(jù)資源介紹》課件
- 麻風(fēng)病病情分析
- 《急診科建設(shè)與設(shè)備配置標(biāo)準(zhǔn)》
- 第一章-地震工程學(xué)概論
- JJF(陜) 063-2021 漆膜沖擊器校準(zhǔn)規(guī)范
- 《中國糖尿病防治指南(2024版)》更新要點(diǎn)解讀
- TSGD7002-2023-壓力管道元件型式試驗(yàn)規(guī)則
- 2024年度家庭醫(yī)生簽約服務(wù)培訓(xùn)課件
評(píng)論
0/150
提交評(píng)論